LC–MS-based quantitation of proteomic changes induced by Norcantharidin in MTB-Treated macrophages

Yi-Lin Wu,Yuan-Ting Li,Gan-Bin Liu,Jin-Lin Wu,Xiao-Ran Liu,Xin-Xuan Gao,Qi-Dan Huang,Jin Liang,Jia-Yi Ouyang,Yi-Ran Ding,Jun-Yi Wu,Yuan-Bin Lu,Yu-Chi Gao,Xiao-Zhen Cai,Jun-Ai Zhang
DOI: https://doi.org/10.1186/s12953-024-00235-y
2024-12-06
Proteome Science
Abstract:Tuberculosis drug resistance contributes to the spread of tuberculosis. Immunotherapy is an effective strategy for treating tuberculosis, with the regulation of macrophage-mediated anti-tuberculosis immunity being crucial. Norcantharidin (NCTD), a drug used in tumor immunotherapy, has significant immunomodulatory effects. Thus, NCTD may have an anti-tuberculosis role by regulating immunity. Understanding how NCTD affects the proteome of Mtb -infected macrophages can provide valuable insights into potential treatments. This study aimed to investigate the impact of NCTD (10 μg/mL) on the proteome of macrophages infected with Mtb H37Ra using liquid chromatography-tandem mass spectrometry (LC–MS/MS) analysis. A total of 69 differentially regulated proteins (DRPs) were identified, with 28 up-regulated and 41 down-regulated in the NCTD-treated group. Validation of six DRPs (CLTCL1, VAV1, SP1, TRIM24, MYO1G, and WDR70) by Western blot analysis confirmed the accuracy of the LC–MS/MS method used in this study. NCTD modulates various protein expressions involved in chromatin-modifying enzymes, RHO GTPases activating PAKs, Fc gamma R-mediated phagocytosis, T cell receptor signaling pathway, and antigen processing and presentation. Overall, the research provides new insights into the effects of NCTD on the proteome of Mtb -infected macrophages. The identified changes highlight potential targets for future therapeutic interventions aimed at enhancing host immunity against Mtb infection or developing new anti-TB drugs based on these findings.
biochemical research methods
What problem does this paper attempt to address?